Apoptosis in renal proximal tubules of rats treated with low doses of aminoglycosides

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 3, 2000, Pages 665-675

  El Mouedden, Mohammed ^a   Laurent, Guy ^b   Mingeot Leclercq, Marie Paule ^a   Taper, Henryk S ^a   Cumps, Jean ^a   Tulkens, Paul M ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b UNIVERSITY OF MONS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; GENTAMICIN; ISEPAMICIN; NETILMICIN;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; AUTORADIOGRAPHY; DNA SYNTHESIS; DOSE RESPONSE; FEMALE; GRAM NEGATIVE SEPSIS; IMMUNOHISTOCHEMISTRY; KIDNEY PROXIMAL TUBULE; LIPIDOSIS; NONHUMAN; PRIORITY JOURNAL; RAT; STATISTICAL ANALYSIS;

AMIKACIN; ANIMALS; ANTI-BACTERIAL AGENTS; APOPTOSIS; BLOOD UREA NITROGEN; CELL DIVISION; CREATININE; FEMALE; GENTAMICINS; IN SITU NICK-END LABELING; KIDNEY CORTEX; KIDNEY TUBULES, PROXIMAL; NETILMICIN; PHOSPHOLIPIDS; RATS; RATS, WISTAR;

EID: 0034001860     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.3.665-675.2000     Document Type: Article

References (77)

1. Alison, M. R., and C. E. Sarraf. 1995. Apoptosis: regulation and relevance to toxicology. Hum. Exp. Toxicol. 14:234-247.
2. Aoshiba, K., A. Nagai, and K. Konno. 1995. Erythromycin shortens neutrophil survival by accelerating apoptosis. Antimicrob. Agents Chemother. 39: 872-877.
3. Arends, M. J., and A. H. Wyllie. 1991. Apoptosis: mechanisms and roles in pathology. Int. Rev. Exp. Pathol. 32:2523-2541.
4. Bartels, H., M. Böhmer, and C. Heierli. 1972. Serum Kreatininbestimmung ohne Enteiweissen. Clin. Chim. Acta 37:193-197.
5. Bartlett, G. R. 1959. Phosphorus assay in column chromatography. J. Biol. Chem. 234:466-468.
6. Bennett, W. M., C. E. Plamp, D. N. Gilbert, R. A. Parker, and G. A. Porter. 1979. The influence of dosage regimen on experimental gentamicin nephrotoxicity: dissociation of peak serum levels from renal failure. J. Infect. Dis. 140:576-580.
7. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:911-917.
8. Brachet, J. 1953. The use of basic dyes and ribonuclease for the cytochemical detection of ribonucleic acid. Q. J. Microsc. Sci. 94:1-10.
9. Brunk, U. T., H. Dalen, K. Roberg, and H. B. Hellquist. 1997. Photooxidative disruption of lysosomal membranes causes apoptosis of cultured human fibroblasts. Free Radic. Biol. Med. 23:616-626.
10. Buja, L. M., M. L. Eigenbordt, and E. H. Eigenbordt. 1993. Apoptosis and necrosis: basic types and mechanisms of cell death. Arch. Pathol. Lab. Med. 117:1208-1215.
11. Carlier, M. B., G. Laurent, P. J. Claes, H. J. Vanderhaeghe, and P. M. Tulkens. 1983. Inhibition of lysosomal phospholipases by aminoglycoside antibiotics: in vitro comparative studies. Antimicrob. Agents Chemother. 23: 440-449.
12. Coles, H. S. R., J. F. Burne, and M. C. Raff. 1993. Large scale normal cell death in the developing rat kidney and its reduction by epidermal growth factor. Development 118:777-784.
13. Conaldi, P. G., L. Biancone, A. Bottelli, A. Wade-Evans, L. C. Racusen, M. Boccellino, and A. Toniolo. 1998. HIV-1 kills renal tubular epithelial cells in vitro by triggering an apoptotic pathway involving caspase activation and Fas upregulation. J. Clin. Investig. 102:2041-2049.
14. Davis, M. A., and D. H. Ryan. 1998. Apoptosis in the kidney. Toxicol. Pathol. 26:810-825.
15. DiGiorgio, J. 1974. Nonprotein nitrogenous constituents, p. 503-564. In R. J. Henry, D. C. Cannon, and J. W. Winkelman (ed), Clinical chemistry: principles and techniques, 2nd ed. Harper and Row Publishers, Inc., New York, N.Y.
16. Enari, M., H. Sakahira, H. Yokoyama, K. Okawa, A. Iwamatsu, and S. Nagata. 1998. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391:43-50.
17. Fadok, V. A., D. R. Voelker, P. A. Campbell, J. J. Cohen, D. L. Bratton, and P. M. Henson. 1992. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148:2207-2216.
18. Fine, L. G., M. R. Hammerman, and H. E. Abboud. 1992. Evolving role of growth factors in the renal response to acute and chronic disease. J. Am. Soc. Nephrol. 2:1163-1170.
19. Gavrieli, Y., Y. Sherman, and S. A. Ben-Sasson. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:493-501.
20. Gilbert, D. N. 1995. Aminoglycosides, p. 279-306. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious diseases, 4th ed. Churchill Livingstone, New York, N.Y.
21. Gilbert, D. N. 1997. Editorial response: meta-analyses are no longer required for determining the efficacy of single daily dosing of aminoglycosides. Clin. Infect. Dis. 24:816-819.
22. Gobe, G. C., and R. A. Axelsen. 1987. Genesis of renal tubular atrophy in experimental hydronephrosis in the rat. Role of apoptosis. Lab. Investig 56: 273-282.
23. Green, D. R., and J. C. Reed. 1998. Mitochondria and apoptosis. Science 281: 1309-1312.
24. Hagiwara, M., M. Inagaki, K. Kanamura, H. Ohta, and H. Hidaka. 1988. Inhibitory effects of aminoglycosides on renal protein phosphorylation by protein kinase C. J. Pharmacol. Exp. Ther. 244:355-360.
25. Herman, E. H., J. Zhang, B. B. Hasinoff, J. R. Clarck, and V. J. Ferrans. 1997. Comparison of the structural changes induced by doxorubicin and mitoxantrone in the heart, kidney and intestine and characterization of the Fe(III)-mitoxantrone complex. J. Mol. Cell. Cardiol. 29:2415-2430.
26. Hottendorf, G. H., D. Barnett, L. L. Gordon, E. F. Christensen, and H. Madissoo. 1981. Nonparallel nephrotoxicity dose-response curves of aminoglycosides. Antimicrob. Agents Chemother. 19:1024-1028.
27. Ibrahim, S., F. Clerckx-Braun, P. Jacqmin, J. Donnez, V. Brulein, and P. M. Tulkens. 1991. Effect of the schedule of administration of two aminoglycosides, netilmicin and amikacin on urinary, phospholipid excretion in humans, p. 93-97. In P. H. Bach, N. J. Gregg, M. F. Wilks, and L. Delacruz (ed.), Nephrotoxicity: mechanisms, early diagnosis and therapeutic management. Marcel Dekker, New York, N.Y.
28. Ibrahim, S., P. Van der Auwera, F. Meunier, and P. M. Tulkens. 1989. Effect of netilmicin and amikacin on urinary phospholipid excretion in humans. Arch. Toxicol. 13(Suppl.):413-416.
29. Igarashi, M., J. K. Levy, and J. Jerger. 1978. Comparative toxicity of netilmicin and gentamicin in squirrel monkeys (Saimiri sciureus). J. Infect. Dis. 137:476-480.
30. Ishisaka, R., T. Utsumi, M. Yabuki, T. Kanno, T. Furuno, M. Inoue, and K. Utsumi. 1998. Activation of caspase-3-like protease by digitonin-treated lysosomes. FEBS Lett. 435:233-236.
31. Jaffé, M. 1886. Über den Niederschlag welchen Pikrinsäure in normalen Harn erzeugt und über eine neue Reaktion des Kreatinins. Z. Physiol. Chem. 10:391-400.
32. Josepovitz, C., R. Levine, B. Lane, and G. J. Kaloyanides. 1985. Contrasting effects of gentamicin and mercuric chloride on urinary excretion of enzymes and phospholipids in the rat. Lab. Investig. 52:375-386.
33. Kerr, J. F. R., A. H. Wyllie, and A. R. Currie. 1972. Apoptosis: a basic biological phenomenon with wide ranging implications in tissue kinetics. J. Cancer 26:239-257.
34. Kishore, B. K., S. Ibrahim, P. Lambricht, G. Laurent, P. Maldague, and P. M. Tulkens. 1992. Comparative assessment of poly-L-aspartic and poly-L-glutamic acids against gentamicin-induced renal lysosomal phospholipidosis, phospholipiduria and cell proliferation in rats. J. Pharmacol. Exp. Ther. 262:424-432.
35. Kockx, M. M., J. Muhring, M. W. M. Knaapen, and G. R. Y. de Meyer. 1998. RNA synthesis and splicing interferes with DNA in situ end labeling techniques used to detect apoptosis. Am. J. Pathol. 152:885-888.
36. Lang, H., and C. Liu. 1997. Apoptosis and hair cell degeneration in the vestibular sensory epithelia of the guinea pig following a gentamicin insult. Hear. Res. 111:177-184.
37. Laurent, G., B. K. Kishore, and P. M. Tulkens. 1990. Aminoglycoside-induced phospholipidosis and nephrotoxicity, Biochem. Pharmacol. 40:2383-2392.
38. Laurent, G., P. Maldague, M. B. Carlier, and P. Tulkens. 1983. Increased renal DNA synthesis in vivo after administration of low doses of gentamicin to rats. Antimicrob. Agents Chemother. 24:586-593.
39. Laurent, G., G. Toubeau, J. A. Heuson-Stiennon, P. Tulkens, and P. Maldague. 1988. Kidney tissue repair after nephrotoxic injury: biochemical and morphological characterization. Crit. Rev. Toxicol. 19:147-183.
40. Lieberthal, W., and J. S. Levine. 1996. Mechanisms of apoptosis and its potential role in renal tubular epithelial cell injury. Am. J. Physiol. 271: F471-F488.
41. Lieberthal, W., V. Triaca, and J. Levine. 1996. Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: apoptosis vs necrosis. Am. J. Physiol. 270:F700-F708.
42. Lipsky, J. J., and P. S. Lietman. 1982. Aminoglycoside inhibition of a renal phosphatidylinositol phospholipase C. J. Pharmacol. Exp. Ther. 220:287-292.
43. Lockshin, R. A., and C. M. Williams. 1965. Programmed cell death. 1. Cytology of the degeneration in the intersegmental muscles of peryi silk-moth. J. Insect Physiol. 11:123-133.
44. Lockshin, R. A., and Z. Zakeri. 1991. Programmed cell death and apoptosis. p. 47-60. In L. D. Tomei and F. O. Coppe (ed.), Apoptosis: the molecular basis of cell death. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
45. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
46. Marche, P., B. Olier, A. Girard, J. P. Fillastre, and J. P. Morin. 1987. Aminoglycoside-induced alterations of phosphoinositide metabolism. Kidney Int. 31:59-64.
47. Miao, J. Y., K. Kaji, H. Hayashi, and S. Araki. 1997. Inhibitors of phospholipase promote apoptosis of human endothelial cells. J. Biochem. 121:612-618.
48. Mingeot-Leclercq, M. P., and P. M. Tulkens. 1999. Aminoglycosides: nephrotoxicity. Antimicrob. Agents Chemother. 43:1003-1012.
49. Mingeot-Leclercq, M. P., Y. Glupczynski, and P. M. Tulkens. 1999. Aminoglycosides: activity and resistance. Antimicrob. Agents Chemother. 43:727-737.
50. Nagakawa, T., H. Yamane, M. Takayama, K. Sunami, and Y. Nakai. 1998. Apoptosis of guinea pig cochlear hair cells following chronic aminoglycoside treatment. Eur. Arch. Otorhinolaryngol. 255:127-131.
51. Nouwen, E. J., W. A. Verstrepen, N. Buyssens, M.-Q. Zhu, and M. E. De Broe. 1994. Hyperplasia, hypertrophy, and phenotypic alterations in the distal nephron after acute proximal tubular injury in the rat. Lab. Investig. 70:479-493.
52. Parker, R. A., W. H. Bennett, and G. A. Porter. 1982. Animal models in the study of aminoglycoside nephrotoxicity, p. 235-267. In A. Whelton and H. C. Neu (ed.), The aminoglycosides: microbiology, clinical use and toxicology. Marcel Dekker, Inc., New York, N. Y.
53. Parker, R. A., D. N. Gilbert, D. C. Houghton, G. A. Porter, and W. M. Bennett. 1980. Comparative nephrotoxicities of high-dose netilmicin and tobramycin in rats. Antimicrob. Agents Chemother. 18:346-348.
54. Porter, G. A., G. Laurent, P. Maldague, and P. M. Tulkens. 1984. Gentamicin-induced stimulation of DNA synthesis in rat kidney cortex. Comparison between in vivo and in vitro models. Toxicol. Lett. 23:205-213.
55. Racusen, L. 1998. Epithelial cell shedding in acute renal injury. Clin. Exp. Pharmacol. Physiol. 25:273-275.
56. Racusen, L. C., B. A. Fivush, V. L. Li, I. Slatnik, and K. Solez. 1991. Dissociation of tubular cell detachment and tubular cell death in clinical and experimental acute tubular necrosis. Lab. Investig. 64:546-556.
57. Savill, J., I. Dransfield, N. Hogg, and C. Haslett. 1990. Vitronectin receptor mediated phagocytosis of cells undergoing apoptosis. Nature 343:170-173.
58. Savill, J. S., V. Fadok, P. Henson, and C. Haslett. 1993. Phagocyte recognition of cells undergoing apoptosis. Immunol. Today 14:131-136.
59. Savill, J. S., P. M. Henson, and C. Haslett. 1989. Phagocytosis of aged human neutrophils by macrophages is mediated by novel "charge sensitive" recognition mechanism. J. Clin. Investig. 84:1518-1527.
60. Schwertz, D. W., J. I. Kreisberg, and M. A. Venkatachalam. 1984. Effects of aminoglycosides on proximal tubule brush border membrane phosphatidylinositol-specific phospholipase C. J. Pharmacol. Exp. Ther. 231:48-55.
61. Serlachius, E., J. Svennilson, M. Schalling, and A. Asperia. 1997. Protein kinase C in the developing kidney: isoform expression and effects of ceramide and PKC inhibitors. Kidney Int. 52:901-910.
62. Shimizu, A., and N. Yamada. 1993. Apoptosis and cell desquamation in repair process of ischemic tubular necrosis. Mol. Pathol. 64:171-180.
63. Simmons, C. F., J. Ronald, T. Bogusky, and H. D. Humes. 1980. Inhibitory effects of gentamicin on renal mitochondrial oxidative phosphorylation. J. Pharmacol. Exp. Ther. 214:709-715.
64. Szot, R. J., G. McCormick, M. Chung, B. Christie, E. Weinberg, and E. Schwartz. 1980. Comparative toxicity of netilmicin and tobramycin in dogs. Toxicol. Appl. Pharmacol. 55:169-178.
65. Tanimoto, A., T. Hamada, and O. Koide. 1993. Cell death and regeneration of renal proximal tubular cells in rats with subchronic cadmium intoxication. Toxicol. Pathol. 21:341-352.
66. Thompson, C. B. 1995. Apoptosis in the pathogenesis and treatment of disease. Science 267:1456-1462.
67. Toubeau, G., G. Laurent, M. B. Carlier, S. Abid, P. Maldague, J. A. Heuson-Stiennon, and P. M. Tulkens. 1986. Tissue repair in rat kidney cortex after short treatment with aminoglycosides at low doses: a comparative biochemical and morphometric study. Lab. Investig. 54:385-393.
68. Tulkens, P., and A. Trouet. 1978. The uptake and intracellular accumulation of aminoglycoside antibiotics in lysosomes of cultured rat fibroblasts. Biochem. Pharmacol. 27:415-424.
69. Tulkens, P., G. Laurent, M. B. Carlier, G. Toubeau, J. Heuson-Stiennon, and P. Maldague. 1983. Comparative study of the alterations induced in rat kidney by gentamicin, dibekacin, netilmicin, tobramycin and amikacin at low doses, p. 30-35. In K. H. Spitzy and K. Karrer (ed.). Proceedings of the 13th International Congress of Chemotherapy, Vienna, Austria.
70. Tulkens, P. M. 1986. Experimental studies on nephrotoxicity of aminoglycosides at low doses: mechanisms and perspectives. Am. J. Med. 80:105-114.
71. Tulkens, P. M., M. E. De Brot, P. Maldague, and J. A. Heuson-Stiennon. 1983. Lysosomal alterations in aminoglycoside-induced acute renal failure, p. 299-327. In K. Solez and A. Whelton (ed.). Acute renal failure: correlations between morphology and function. Marcel Dekker, New York, N.Y.
72. Tulkens, P. M., M. P. Mingeot-Leclercq, G. Laurent, and R. Brasseur. 1990. Conformational and biochemical analysis of the interactions between phospholipids and aminoglycoside antibiotics in relation with their toxicity, p. 63-93. In R. Brasseur (ed.), Molecular description of biological membrane components by computer-aided conformational analysis. CRC Press, Inc., Boca Raton, Fla.
73. Ueda, N., and S. V. Shah. 1994. Apoptosis. J. Lab. Clin. Med. 124:169-177.
74. Vermes, I., and C. Haanen. 1994. Apoptosis and programmed cell death in health and disease. Adv. Clin. Chem. 31:177-246.
75. Weinberg, J. M. 1986. The role of cell calcium overload in nephrotoxic renal tubular cell injury. Am. J. Kidney Dis. 8:284-291.
76. Weinberg, J. M., and H. D. Humes. 1980. Mechanisms of gentamicin-induced dysfunction of renal cortical mitochondria. I. Effects on mitochondrial respiration. Arch. Biochem. Biophys. 205:222-231.
77. Weinberg, J. M., P. G. Harding, and H. D. Humes. 1980. Mechanisms of gentamicin-induced dysfunction of renal cortical mitochondria. II. Effects on mitochondrial monovalent cation transport. Arch. Biochem. Biophys. 205: 232-239.